HEADER PROTEIN FIBRIL 19-FEB-22 7U13 TITLE TMEM106B(120-254) SINGLET AMYLOID FIBRIL FROM FRONTOTEMPORAL LOBAR TITLE 2 DEGENERATION WITH TDP-43 PATHOLOGY (FTLD-TDP) TYPE A (CASE 4) COMPND MOL_ID: 1; COMPND 2 MOLECULE: TRANSMEMBRANE PROTEIN 106B; COMPND 3 CHAIN: A, B, C; COMPND 4 FRAGMENT: UNP RESIDUES 120-254; COMPND 5 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: TMEM106B; SOURCE 6 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 7 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 9606 KEYWDS TMEM106B, AMYLOID FIBRIL, PROTEIN FIBRIL EXPDTA ELECTRON MICROSCOPY AUTHOR A.W.P.FITZPATRICK,M.H.B.STOWELL,A.CHANG,X.XIANG,J.WANG,C.LEE, AUTHOR 2 T.ARAKHAMIA,M.SIMJANOSKA,C.WANG,Y.CARLOMAGNO,G.ZHANG,S.DHINGRA, AUTHOR 3 M.THIERRY,J.PERNEEL,B.HEEMAN,L.M.FORGRAVE,M.DETURE,M.L.DEMARCO, AUTHOR 4 C.N.COOK,R.RADEMAKERS,D.DICKSON,L.PETRUCELLI,I.R.A.MACKENZIE REVDAT 2 27-APR-22 7U13 1 JRNL REVDAT 1 23-MAR-22 7U13 0 JRNL AUTH A.CHANG,X.XIANG,J.WANG,C.LEE,T.ARAKHAMIA,M.SIMJANOSKA, JRNL AUTH 2 C.WANG,Y.CARLOMAGNO,G.ZHANG,S.DHINGRA,M.THIERRY,J.PERNEEL, JRNL AUTH 3 B.HEEMAN,L.M.FORGRAVE,M.DETURE,M.L.DEMARCO,C.N.COOK, JRNL AUTH 4 R.RADEMAKERS,D.W.DICKSON,L.PETRUCELLI,M.H.B.STOWELL, JRNL AUTH 5 I.R.A.MACKENZIE,A.W.P.FITZPATRICK JRNL TITL HOMOTYPIC FIBRILLIZATION OF TMEM106B ACROSS DIVERSE JRNL TITL 2 NEURODEGENERATIVE DISEASES. JRNL REF CELL V. 185 1346 2022 JRNL REFN ISSN 1097-4172 JRNL PMID 35247328 JRNL DOI 10.1016/J.CELL.2022.02.026 REMARK 2 REMARK 2 RESOLUTION. 2.90 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : NULL REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : NULL REMARK 3 REFINEMENT SPACE : NULL REMARK 3 REFINEMENT PROTOCOL : NULL REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 2.900 REMARK 3 NUMBER OF PARTICLES : 143000 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 7U13 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 21-FEB-22. REMARK 100 THE DEPOSITION ID IS D_1000263347. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : HELICAL REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : FILAMENT REMARK 245 PARTICLE TYPE : HELICAL REMARK 245 NAME OF SAMPLE : TMEM106B(120-254) SINGLET REMARK 245 AMYLOID FIBRIL FROM DEMENTIA REMARK 245 WITH LEWY BODIES (DLB) REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : NULL REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : NULL REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : NULL REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K3 BIOQUANTUM (6K X REMARK 245 4K) REMARK 245 MINIMUM DEFOCUS (NM) : 1400.00 REMARK 245 MAXIMUM DEFOCUS (NM) : 2800.00 REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : NULL REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 6000.00 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 THE ASSEMBLY REPRESENTED IN THIS ENTRY HAS REGULAR REMARK 300 HELICAL SYMMETRY WITH THE FOLLOWING PARAMETERS: REMARK 300 ROTATION PER SUBUNIT (TWIST) = -0.40 DEGREES REMARK 300 RISE PER SUBUNIT (HEIGHT) = 4.80 ANGSTROMS REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OH TYR A 197 NZ LYS B 220 2.12 REMARK 500 NE2 GLN C 229 OG1 THR C 234 2.14 REMARK 500 NE2 GLN B 229 OG1 THR B 234 2.14 REMARK 500 NE2 GLN A 229 OG1 THR A 234 2.14 REMARK 500 OH TYR B 197 NZ LYS C 220 2.17 REMARK 500 O GLN B 138 OG1 THR B 141 2.18 REMARK 500 O GLN A 138 OG1 THR A 141 2.18 REMARK 500 O GLN C 138 OG1 THR C 141 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 PRO A 189 CB PRO A 189 CG -0.432 REMARK 500 PRO A 189 CG PRO A 189 CD -0.328 REMARK 500 PRO B 189 CB PRO B 189 CG -0.432 REMARK 500 PRO B 189 CG PRO B 189 CD -0.329 REMARK 500 PRO C 189 CB PRO C 189 CG -0.432 REMARK 500 PRO C 189 CG PRO C 189 CD -0.329 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 189 CA - CB - CG ANGL. DEV. = -30.3 DEGREES REMARK 500 PRO A 189 CB - CG - CD ANGL. DEV. = 73.5 DEGREES REMARK 500 PRO A 189 N - CD - CG ANGL. DEV. = -29.4 DEGREES REMARK 500 PRO B 189 CA - CB - CG ANGL. DEV. = -30.2 DEGREES REMARK 500 PRO B 189 CB - CG - CD ANGL. DEV. = 73.4 DEGREES REMARK 500 PRO B 189 N - CD - CG ANGL. DEV. = -29.2 DEGREES REMARK 500 PRO C 189 CA - CB - CG ANGL. DEV. = -30.3 DEGREES REMARK 500 PRO C 189 CB - CG - CD ANGL. DEV. = 73.4 DEGREES REMARK 500 PRO C 189 N - CD - CG ANGL. DEV. = -29.2 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ILE A 121 -60.57 -121.80 REMARK 500 VAL A 128 -50.10 -127.43 REMARK 500 ASN A 145 64.72 61.33 REMARK 500 LYS A 178 50.71 37.55 REMARK 500 PRO A 189 161.21 -44.74 REMARK 500 LEU A 190 63.22 60.80 REMARK 500 ILE B 121 -60.70 -121.83 REMARK 500 ASN B 145 64.82 61.18 REMARK 500 LYS B 178 50.71 37.43 REMARK 500 PRO B 189 161.25 -44.68 REMARK 500 LEU B 190 63.17 60.76 REMARK 500 ILE C 121 -60.60 -121.87 REMARK 500 ASN C 145 64.86 61.24 REMARK 500 LYS C 178 50.75 37.45 REMARK 500 PRO C 189 161.19 -44.72 REMARK 500 LEU C 190 63.20 60.79 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 GLN A 138 LYS A 139 -147.51 REMARK 500 GLN B 138 LYS B 139 -147.55 REMARK 500 GLN C 138 LYS C 139 -147.46 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-26276 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26268 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26273 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26274 RELATED DB: EMDB REMARK 900 RELATED ID: EMD-26275 RELATED DB: EMDB DBREF 7U13 A 120 254 UNP Q9NUM4 T106B_HUMAN 120 254 DBREF 7U13 B 120 254 UNP Q9NUM4 T106B_HUMAN 120 254 DBREF 7U13 C 120 254 UNP Q9NUM4 T106B_HUMAN 120 254 SEQRES 1 A 135 SER ILE ASP VAL LYS TYR ILE GLY VAL LYS SER ALA TYR SEQRES 2 A 135 VAL SER TYR ASP VAL GLN LYS ARG THR ILE TYR LEU ASN SEQRES 3 A 135 ILE THR ASN THR LEU ASN ILE THR ASN ASN ASN TYR TYR SEQRES 4 A 135 SER VAL GLU VAL GLU ASN ILE THR ALA GLN VAL GLN PHE SEQRES 5 A 135 SER LYS THR VAL ILE GLY LYS ALA ARG LEU ASN ASN ILE SEQRES 6 A 135 THR ILE ILE GLY PRO LEU ASP MET LYS GLN ILE ASP TYR SEQRES 7 A 135 THR VAL PRO THR VAL ILE ALA GLU GLU MET SER TYR MET SEQRES 8 A 135 TYR ASP PHE CYS THR LEU ILE SER ILE LYS VAL HIS ASN SEQRES 9 A 135 ILE VAL LEU MET MET GLN VAL THR VAL THR THR THR TYR SEQRES 10 A 135 PHE GLY HIS SER GLU GLN ILE SER GLN GLU ARG TYR GLN SEQRES 11 A 135 TYR VAL ASP CYS GLY SEQRES 1 B 135 SER ILE ASP VAL LYS TYR ILE GLY VAL LYS SER ALA TYR SEQRES 2 B 135 VAL SER TYR ASP VAL GLN LYS ARG THR ILE TYR LEU ASN SEQRES 3 B 135 ILE THR ASN THR LEU ASN ILE THR ASN ASN ASN TYR TYR SEQRES 4 B 135 SER VAL GLU VAL GLU ASN ILE THR ALA GLN VAL GLN PHE SEQRES 5 B 135 SER LYS THR VAL ILE GLY LYS ALA ARG LEU ASN ASN ILE SEQRES 6 B 135 THR ILE ILE GLY PRO LEU ASP MET LYS GLN ILE ASP TYR SEQRES 7 B 135 THR VAL PRO THR VAL ILE ALA GLU GLU MET SER TYR MET SEQRES 8 B 135 TYR ASP PHE CYS THR LEU ILE SER ILE LYS VAL HIS ASN SEQRES 9 B 135 ILE VAL LEU MET MET GLN VAL THR VAL THR THR THR TYR SEQRES 10 B 135 PHE GLY HIS SER GLU GLN ILE SER GLN GLU ARG TYR GLN SEQRES 11 B 135 TYR VAL ASP CYS GLY SEQRES 1 C 135 SER ILE ASP VAL LYS TYR ILE GLY VAL LYS SER ALA TYR SEQRES 2 C 135 VAL SER TYR ASP VAL GLN LYS ARG THR ILE TYR LEU ASN SEQRES 3 C 135 ILE THR ASN THR LEU ASN ILE THR ASN ASN ASN TYR TYR SEQRES 4 C 135 SER VAL GLU VAL GLU ASN ILE THR ALA GLN VAL GLN PHE SEQRES 5 C 135 SER LYS THR VAL ILE GLY LYS ALA ARG LEU ASN ASN ILE SEQRES 6 C 135 THR ILE ILE GLY PRO LEU ASP MET LYS GLN ILE ASP TYR SEQRES 7 C 135 THR VAL PRO THR VAL ILE ALA GLU GLU MET SER TYR MET SEQRES 8 C 135 TYR ASP PHE CYS THR LEU ILE SER ILE LYS VAL HIS ASN SEQRES 9 C 135 ILE VAL LEU MET MET GLN VAL THR VAL THR THR THR TYR SEQRES 10 C 135 PHE GLY HIS SER GLU GLN ILE SER GLN GLU ARG TYR GLN SEQRES 11 C 135 TYR VAL ASP CYS GLY HET NAG A 301 14 HET NAG A 302 14 HET NAG A 303 14 HET NAG A 304 14 HET NAG B 301 14 HET NAG B 302 14 HET NAG B 303 14 HET NAG B 304 14 HET NAG C 301 14 HET NAG C 302 14 HET NAG C 303 14 HET NAG C 304 14 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 4 NAG 12(C8 H15 N O6) SHEET 1 AA1 3 ASP A 122 TYR A 125 0 SHEET 2 AA1 3 ASP B 122 TYR B 125 1 O ASP B 122 N VAL A 123 SHEET 3 AA1 3 ASP C 122 TYR C 125 1 O ASP C 122 N VAL B 123 SHEET 1 AA2 3 LYS A 129 ALA A 131 0 SHEET 2 AA2 3 LYS B 129 ASP B 136 1 O SER B 130 N LYS A 129 SHEET 3 AA2 3 SER A 134 ASP A 136 1 N ASP A 136 O TYR B 135 SHEET 1 AA3 3 LYS A 129 ALA A 131 0 SHEET 2 AA3 3 LYS B 129 ASP B 136 1 O SER B 130 N LYS A 129 SHEET 3 AA3 3 LYS C 129 ASP C 136 1 O TYR C 135 N ASP B 136 SHEET 1 AA4 3 THR A 141 GLY A 177 0 SHEET 2 AA4 3 THR B 141 GLY B 177 1 O ASN B 148 N THR A 147 SHEET 3 AA4 3 THR C 141 GLY C 177 1 O ASN C 148 N THR B 147 SHEET 1 AA5 3 ARG A 180 LEU A 181 0 SHEET 2 AA5 3 ARG B 180 LEU B 181 1 O LEU B 181 N ARG A 180 SHEET 3 AA5 3 ARG C 180 LEU C 181 1 O LEU C 181 N ARG B 180 SHEET 1 AA6 3 ILE A 184 ILE A 187 0 SHEET 2 AA6 3 ILE B 184 ILE B 187 1 O ILE B 186 N THR A 185 SHEET 3 AA6 3 ILE C 184 ILE C 187 1 O ILE C 186 N THR B 185 SHEET 1 AA7 3 ASP A 191 THR A 198 0 SHEET 2 AA7 3 ASP B 191 THR B 198 1 O TYR B 197 N ASP A 196 SHEET 3 AA7 3 ASP C 191 THR C 198 1 O TYR C 197 N ASP B 196 SHEET 1 AA8 3 THR A 201 ILE A 203 0 SHEET 2 AA8 3 THR B 201 ILE B 203 1 O ILE B 203 N VAL A 202 SHEET 3 AA8 3 THR C 201 ILE C 203 1 O ILE C 203 N VAL B 202 SHEET 1 AA9 3 TYR A 209 ILE A 219 0 SHEET 2 AA9 3 TYR B 209 ILE B 219 1 O PHE B 213 N CYS A 214 SHEET 3 AA9 3 TYR C 209 ILE C 219 1 O PHE C 213 N CYS B 214 SHEET 1 AB1 3 HIS A 222 MET A 228 0 SHEET 2 AB1 3 HIS B 222 MET B 228 1 O VAL B 225 N LEU A 226 SHEET 3 AB1 3 HIS C 222 MET C 228 1 O VAL C 225 N LEU B 226 SHEET 1 AB2 3 THR A 233 GLN A 245 0 SHEET 2 AB2 3 THR B 233 GLN B 245 1 O GLN B 245 N SER A 244 SHEET 3 AB2 3 THR C 233 GLN C 245 1 O PHE C 237 N GLY B 238 SHEET 1 AB3 3 GLN A 249 CYS A 253 0 SHEET 2 AB3 3 GLN B 249 CYS B 253 1 O TYR B 250 N VAL A 251 SHEET 3 AB3 3 GLN C 249 CYS C 253 1 O TYR C 250 N VAL B 251 SSBOND 1 CYS A 214 CYS A 253 1555 1555 2.04 SSBOND 2 CYS B 214 CYS B 253 1555 1555 2.04 SSBOND 3 CYS C 214 CYS C 253 1555 1555 2.03 LINK ND2 ASN A 145 C1 NAG A 303 1555 1555 1.44 LINK ND2 ASN A 151 C1 NAG A 302 1555 1555 1.44 LINK ND2 ASN A 164 C1 NAG A 304 1555 1555 1.44 LINK ND2 ASN A 183 C1 NAG A 301 1555 1555 1.45 LINK ND2 ASN B 145 C1 NAG B 303 1555 1555 1.44 LINK ND2 ASN B 151 C1 NAG B 302 1555 1555 1.44 LINK ND2 ASN B 164 C1 NAG B 304 1555 1555 1.44 LINK ND2 ASN B 183 C1 NAG B 301 1555 1555 1.45 LINK ND2 ASN C 145 C1 NAG C 303 1555 1555 1.44 LINK ND2 ASN C 151 C1 NAG C 302 1555 1555 1.44 LINK ND2 ASN C 164 C1 NAG C 304 1555 1555 1.44 LINK ND2 ASN C 183 C1 NAG C 301 1555 1555 1.45 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000